5thPort to Exhibit at Clinical Trials Ontario Virtual Conference
5thPort™ is excited to exhibit at Clinical Trials Ontario (CTO) 2021's virtual conference, scheduled for March 23, 24, and 25, 2021.
5thPort Simplifies Adoption of eConsent Technology with FDA 21 CFR Part 11 Compliance
In our continued commitment to helping our clients satisfy their audit requirements, we're pleased to announce that the 5thPort eConsent and patient engagement platform has been certified as compliant with FDA 21 CFR Part 11 & EU's EUDRALEX ANNEX 11.